AI, multi-omics, and precision medicine are redefining how breakthroughs happen in life sciences. As the pace of discovery accelerates, the challenge is no longer generating data - it’s making it usable, trustworthy, and connected so insights can turn into impact faster.
Elucidata partners with leading pharma, biotech, and diagnostics organizations to make this possible - unifying siloed datasets, preparing AI-ready data at scale, and powering advanced analytics. Our platform, Polly, enables everything from LLM-driven metadata extraction to multi-omics harmonization, helping teams move from raw data to decisions at record speed.
At BioTechX USA 2025, we’ll showcase how our solutions are driving real-world impact in drug discovery, diagnostics, and precision medicine. Shubhra Agrawal and Rahul Tyagi from Elucidata will be there to connect with peers, exchange insights, and explore new collaborations.
%201.svg){kind=icon}
Handpicked Resources for you!
- Cancer Therapy Breakthrough: Elucidata helps ID Novel Targets, Advance to Trials, saves $236 Millions
- Leading Oncology Company Uses Elucidata’s Drug OmixAtlas to Drive Drug Discovery
- Harmonizing Clinical Data for AE Predictions
- AI-Powered Risk Prediction for Oncology Trials: A Case Study in Faster, Safer Decision-Making
At the event, we will be talking all about:
- Rare Diseases in Genomics
- AI in Drug Development and Discovery
- Large Language Models
- AI in Clinical Trials
- Big Data in Oncology
- Bioinformatics and In Silico R&D
Meet the Expert of this discussion
Meet our Co-founder and CEO at the event
Please check your inbox shortly!
.svg)
.svg)
.svg)
info@elucidata.io
%201%20(1).svg)
%20(1).svg)
%201%20(1).svg)
.svg)